2020
DOI: 10.1016/j.lpm.2020.104035
|View full text |Cite
|
Sign up to set email alerts
|

Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
46
0
8

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(54 citation statements)
references
References 64 publications
0
46
0
8
Order By: Relevance
“…IgA vasculitis, also known as Henoch-Schonlein purpura, is a rare disease in the adult population. Prevalence rates in the adult population have varied in literature but are as rare as 0.1 in 100,000 [ 1 ]. In the geriatric population, cases are even more sparse with true prevalence rates being relatively unknown.…”
Section: Introductionmentioning
confidence: 99%
“…IgA vasculitis, also known as Henoch-Schonlein purpura, is a rare disease in the adult population. Prevalence rates in the adult population have varied in literature but are as rare as 0.1 in 100,000 [ 1 ]. In the geriatric population, cases are even more sparse with true prevalence rates being relatively unknown.…”
Section: Introductionmentioning
confidence: 99%
“…A randomized controlled trial about intravenous cyclophosphamide (IVCY) demonstrated that the addition of cyclophosphamide to steroid administration provides no benefit compared with steroid administration alone [ 11 ]. On the other hand, there have been a few reports that IVCY is effective for severe HSP nephritis [ 12 ]. IVCY is effective for other types of systemic vasculitis, such as lupus nephritis and Wegener granulomatosis, with renal involvement [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…The clinical manifestations of IgAV in adults can vary significantly from its monophasic childhood presentation. The common spectrum of disease includes cutaneous purpura, arthralgia (61%), acute enteritis (48–53%) and glomerulonephritis (45–85%) [ 4 , 8 , 9 ]. Symmetric palpable purpura is nearly constant in patients [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…Renal complications are a major determinant of long-term morbidity and mortality of IgAV [ 7 ]. In patients with kidney involvement, 11% will progress to end-stage renal disease (ESRD) [ 9 ]. Poor prognosis factors are impaired renal function at baseline, proteinuria >1 g/day at disease onset, macroscopic hematuria, hypertension, and persistent proteinuria >1 g/day during follow-up [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation